Additive/synergistic anti-tumoral effects of the combination of docetaxel and zoledronic acid on prostate cancer cells: Possible mechanisms?

By Ugur Ural A.   Avcu Ferit  

Acta Oncologica, Vol. 45, Iss. 4, 2006-06 ,pp. : 491-492

Informa Healthcare

Access to resources Recommend Favorite

The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer

By Morgan Claire   Lewis Paul D.   Jones Rachel M.   Bertelli Gianfilippo   Thomas Gerry A.   Leonard Robert C. F.  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 669-677

Informa Healthcare

Access to resources Recommend Favorite

Pain Control with Zoledronic Acid in Patients with Breast Cancer and Metastatic Bone Disease

By Cinzia Nigro   Michela Donadio   Mara Ardine   Alessandra Beano   Marinella Mistrangelo   Zaira Coccorullo   Oscar Bertetto  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 257-263

Adis International

Access to resources Recommend Favorite

Neoadjuvant hormonal therapy and radical prostatectomy in the treatment of clinical stage T3 cancer of the prostate

By Katz G.   Parson J.T.   Wajsman Z.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 6, 1998-11 ,pp. : 203-209

Elsevier

Access to resources Recommend Favorite

Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study

By Ripamonti Carla  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1177-1184

Springer Publishing Company

Access to resources Recommend Favorite